1. Home
  2. EXEL vs YUMC Comparison

EXEL vs YUMC Comparison

Compare EXEL & YUMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exelixis Inc.

EXEL

Exelixis Inc.

N/A

Current Price

$59.01

Market Cap

12.7B

Sector

Health Care

ML Signal

N/A

Logo Yum China Holdings Inc.

YUMC

Yum China Holdings Inc.

N/A

Current Price

$43.60

Market Cap

14.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
EXEL
YUMC
Founded
1994
1987
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
14.8B
IPO Year
2000
2016

Fundamental Metrics

Financial Performance
Metric
EXEL
YUMC
Price
$59.01
$43.60
Analyst Decision
Buy
Analyst Count
21
0
Target Price
$46.50
N/A
AVG Volume (30 Days)
2.2M
1.3M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
2.38%
EPS Growth
57.95
7.73
EPS
1.60
1.57
Revenue
$452,477,000.00
$11,797,000,000.00
Revenue This Year
$13.61
$9.42
Revenue Next Year
$13.13
$5.86
P/E Ratio
$37.20
$27.89
Revenue Growth
N/A
4.37
52 Week Low
$33.76
$40.15
52 Week High
$59.72
$58.39

Technical Indicators

Market Signals
Indicator
EXEL
YUMC
Relative Strength Index (RSI) 65.94 35.97
Support Level $54.30 $42.46
Resistance Level N/A $44.80
Average True Range (ATR) 1.49 1.02
MACD 0.60 -0.59
Stochastic Oscillator 97.76 8.47

Price Performance

Historical Comparison
EXEL
YUMC

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About YUMC Yum China Holdings Inc.

Yum China is the largest restaurant operator in China, with over 18,000 locations and USD 12 billion in systemwide sales as of 2025. It generates revenue primarily from its own restaurants and franchise fees. While KFC and Pizza Hut are its flagship brands, Yum China's portfolio also includes Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza.As a trademark licensee of Yum Brands, Yum China pays 3% of KFC and Pizza Hut's systemwide sales to its former parent, from which it spun off in 2016. However, even before the separation, Yum China was granted substantial autonomy, giving its Chinese leadership decision-making authority over menu, supply chain, and marketing—an unusual practice for Western chains at the time.

Share on Social Networks: